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Abstract 
Purpose: To assess the doses of activated charcoal currently used in the management of acute 
amitriptyline-induced drug poisoning and explore the possibility of using lower doses. 
Methods: Albino male Wistar rats, weighing 200 ± 20 g, were used for the study. The animals were 
divided into four groups of eight animals each. The concentration of amitriptyline in rat plasma was 
measured by high performance liquid chromatography (HPLC) for dose determination of activated 
charcoal. Chromatograms were established with acetonitrile: 70 mM KH2PO4 buffer (60: 40, v/v) solvent 
system on an Xterna® ms C18 SUM column (5 µm, 3.9 × 150 mm) and pH was adjusted to 4.5 with 
ortho-phosphoric acid. Mobile phase flow rate was 1 ml/min and ultraviolet (UV) detection was at 293 
nm. Validation of the method was performed to determine its selectivity, linearity, precision, as well as 
limits of detection (LOD) and of   quantification (LOQ).   
Results: Standard curves were linear, r2 = 0.996, for amitriptyline over the concentration range 10 - 60 
ng/ml. Recovery (98.3 to 100.85 %) was in the selected concentration range of 10 - 60 ng/ml. The LOD 
and LOQ of the method for amitriptyline were 0.109 and 0.332 µg/ml, respectively. The validated 
method was successfully applied to measure plasma concentrations of amitriptyline and to measure the 
doses of activated charcoal currently used in the management of acute amitriptyline drug poisoning. 
Conclusion: The proposed RP-HPLC method enables determination of amitriptyline with good 
separation and resolution of the chromatographic peaks. Validation revealed that the method is 
sensitive, accurate and selective. Using half of the standard dose of the activated charcoal gave a 
comparable effect to the standard dose in reducing drug concentration in the blood. While, using quarter 
of the standard dose of activated charcoal does not have a cleared effect. 
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Poisoning is a global public health concern. 
According to WHO data, in 2004, an estimated 
346,000 people died worldwide from 
unintentional poisoning. Of these deaths, 91 % 
occurred in low- and middle-income countries [1]. 
In Saudi Arabia, annual nationwide data on 
poisoning patterns are scarce and incomplete. 
Most previous studies conducted in Saudi Arabia 
Alotaibi et al 
Trop J Pharm Res, April 2015; 14(4):   
 
656 
that focused on poisoning were city- or region-
specific and failed to present the overall 
epidemiological characteristics and long-term 
trends in poisoning [2-7].  
 
Activated charcoal has been used for the last 
century for gastric decontamination [8].  The 
amount of drug that adsorbs to the activated 
charcoal is dependent on the charcoal-to-drug 
ratio, with the optimal ratio proposed to be 10:1 
[9]. As the dose of drug is rarely known, a 
standard dose of charcoal is normally given. The 
position statement for a single dose of activated 
charcoal suggests a dose of 10 to 25 g (or 0.5 - 
1.0g/kg) of body weight in a child up to 1 year of 
age, 25 to 50 g (or 0.5 - 1.0 g/kg) in children 1 to 
12 years of age, and 25 to 100 g in adolescents 
and adults. However, most children up to 12 
years of age receive a dose of 1 g/kg of body 
weight [10], although there is no single correct 
dose of activated charcoal. 
 
Thus, there is a need to design a study to test 
the use of lower doses than the current standard 
dose of activated charcoal used in the treatment 
of acute drug poisoning, especially for drugs 
used in small doses (such as tricyclic 
antidepressants) to determine the appropriate 
dose of activated charcoal. It is evident from the 
literature that tricyclic antidepressants are 
identified as one of the most frequently ingested 
substances in self-poisoning along with 
paracetamol, benzodiazepines and alcohol [11]. 
There is also evidence that the number of deaths 
relative to the number of prescriptions issued is 
significantly higher for tricyclics than for other 
antidepressants [12].  
 
The objective of this study was to assess the 
activated charcoal doses currently used in the 
management of acute drug poisoning and hence 
explore the possibility of using lower doses of 
activated charcoal, especially for drugs used in 






Amitriptyline and clomipramine (IS) from Sigma-
Aldrich (St Louis, MO, USA) were kindly provided 
by toxicology unit, College of Medicine, King 
Saud University, Riyadh, Saudi Arabia. HPLC-
grade acetonitrile was obtained from Panreac 
Chemicals (Barcelona, Spain), potassium 
dihydrogen phosphate and activated charcoal 
were procured from Winlab Ltd. (Maidenhead, 
Berkshire, UK) and water was produced in the 
laboratory by a Milli-Q purification system 
(Millipore Corp., Billerica, MA, USA). All other 




Instrumentation and chromatographic 
conditions  
 
High performance liquid chromatography (HPLC, 
Waters model 2695 Alliance separation module), 
equipped with UV detector. The chromatographic 
identification was carried out at room 
temperature (25 ± 1 ºC). The mobile phase 
consisted of acetonitrile and potassium 
dihydrogen phosphate buffer (70 mM ), in the 
ratio of 60:40 v/v, which was delivered 
isocratically at a flow rate of 1 ml/min. Xterna® 
ms C18 SUM (5 µm, 3.9 × 150 mm) column was 
utilized to elute the compounds of interest at a 
λmax  =  293 nm for the analysis of amitriptyline. 
 
Selection of mobile phase 
 
Different combinations of solvent systems of 
acetonitrile, buffer (KH2PO4): acetonitrile and 
formic acid: water and methanol: water: 
acetonitrile etc were tried in order to determine 
the best conditions for the separation and 
optimization of amitriptyline. The mobile phase 
consisting of acetonitrile and 70 Mm potassium 
dihydrogen phosphate buffer (KH2PO4) with pH 
adjusted to 4.5 in the ratio of (60:40 % v/v) was 
selected as it gave high resolution for 
amitriptyline with minimal tailing. 
 
Preparation of standard and calibration 
samples 
 
Stock standard solutions of 1 mg/ml amitriptyline 
and the internal standard (IS) clomipramine were 
individually prepared in acetonitrile. These stock 
solutions were kept frozen and used within 2 
weeks. The working standard solution for each 
compound was prepared by serial dilution of the 
stock solution with acetonitrile. Calibration 
standards of plasma samples for UV detection 
were prepared by spiking the plasma with 
working solutions of amitriptyline to make the 
final concentrations of 10, 15, 20, 25, 30, 35, 40, 




Plasma samples kept at -80 ºC were thawed for 
one hour and then vortexed for 30 s at room 
temperature before extraction to ensure 
homogeneity. Amitriptyline was extracted from 
the plasma with acetonitrile as the precipitation 
solvent. To 200 µl of plasma containing 
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amitriptyline, IS (110 ng/ml) was added in a 1.5-
ml capped centrifuge tube with vortex mixing. 
Acetonitrile (140 μl) and 120 μl of concentrated 
potassium phosphate solution (1 g/ml) were 
added. The mixture was shaken and centrifuged 
at 2500 × g for 15 min. The supernatant was 
transferred to another Eppendorf tube and 20 µl 
of this was injected onto the column for the 




Method validation was carried out according to 
ICH guidelines [13] in rat plasma in order to 
evaluate the method for linearity of response, 
accuracy, precision, recovery, limit of detection 
and quantification, selectivity, stability of analyte 
during processing, and storage. 
 
Linearity 
The linearity of an analytical method is its ability 
to elicit test results that are directly proportional 
to the concentration of analyte in samples within 
a given range. Thus, linearity refers to the 
relationship of concentration and assay 
measurement [13]. The linearity of the proposed 
method was evaluated by using calibration 
curves to calculate coefficient of correlation and 
intercept values. 
 
Precision, accuracy and recovery 
 
For precision and accuracy (n = 6) of the method 
was determining by using calibration standard 
solution (30 ng/ml) of amitriptyline and results 
was expressed in terms of % RSD. Recovery 
studies were carried out by applying the method 
to drug samples to which known amount of 
amitriptyline corresponding to higher 
concentration 60 ng/ml and lower concentration 
10 ng/ml. At each level, six determinations were 
performed. 
 
Limit of detection and of quantification (LOD 
and LOQ) 
 
For determination of LOD and LOQ, blank 
plasma samples (without AMT and IS) were 
injected in triplicate for peak area calculations. 
LOD and LOQ were determined from the slope 
(S) of the calibration curve and SD of the 
response for the blank samples as follows: LOD 
= 3.3 × SD/S; and LOQ = 10 × SD/S.  
 
Selectivity and specificity 
 
The selectivity of the method was checked by 
injecting solution of amitriptyline. It was observed 
that sharp peaks for IS and amitriptyline occurred 
at retention times of 4.5 and 6.15 min, 
respectively. These peaks were not present in 
the chromatogram of blank plasma. The 
specificity of the method was assessed by 
comparing chromatograms obtained from drug 
standards with that obtained from plasma of 
animals. The retention times of the drug 
standards and the drugs from treated animals 
were found to be same, indicating the method 
was specific and selective because of no 




The stability (short term) of standard and 
amitriptyline sample solutions was carried out by 
analyzing the drug after 24 and 48 h at room 
temperature and - 20 ºC against fresh standard 
solutions. Long-term stability was evaluated after 
storing samples at –80 oC for 30 days. All 
stability experiments were carried out against 






Albino male Wistar rats weighing approximately 
200 ± 20 g were obtained from the Experimental 
Animal Care Center, College of Pharmacy, King 
Saud University, Riyadh, Saudi Arabia. The 
animals were kept under controlled 
environmental conditions (25 ºC and a 12 h 
light/dark cycle). Animals were given free access 
to pulverized standard rat pellet food and tap 
water. The protocol of this study has been 
approved (clearance number 021015-0618; 
March 10, 2013) by Research Ethics Committee 
of College of Pharmacy, King Saud University, 
Riyadh, Saudi Arabia, and the animals were 
handled in accordance with the Guide for the 
Care and Use of Laboratory Animals by National 




The animals were divided into four groups of 
eight animals each. Group I served as positive 
control received only 1 ml of amitriptyline (2.5 
mg/ml) by oral route. Group- II was administered 
with 1 ml of amitriptyline (2.5 mg/ml) and after 
ten minutes 1 ml of activated charcoal (50 mg/ml, 
i.e., quarter dose of the standard dose of the 
activated charcoal) by oral route. Group III was 
administered 1 ml of amitriptyline (2.5 mg/ml) 
and after ten minutes 1 ml of activated charcoal 
(100 mg/ml, i.e., half dose of the standard dose 
of the activated charcoal). Group IV served as 
standard control and was given 1 ml of 
amitriptyline (2.5 mg/ml) and after ten min,  
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Figure 1:  HPLC chromatogram of (A) blank plasma, (B) plasma spiked with internal standard (I.S), (C) plasma 
sample from the calibration curve of amitriptyline (20 ng/ml; Rt, 6.15 min) and I.S (Rt 4.5 min), and (D) plasma 
sample from rat administered with amitriptyline (2.5 mg/kg, p.o) 
 
1 ml of activated charcoal (200 mg/ml dose, i.e.; 
the standard dose of the activated charcoal). 
Standard dose of the activated charcoal have 
been measured on the basis of the activated 
charcoal dose, 1 g/kg of the body weight. After 
two hours of dosing the animals were 
anesthetized and blood was collected from heart. 
Plasma was separated by centrifugation at 2500 
× g for 10 min and was transferred to pre-labeled 
eppendorf tubes for subsequent analysis of 
amitriptyline concentration using the developed 




Data were statistically analyzed using the 
statistics program (Sigma plot V12) and are 
given as mean ± SEM. Differences between 
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groups were determined by one-way analysis of 
variance (ANOVA) using Student-Newman-Keuls 
method for all pair-wise multiple comparison 





The method was developed and validated 
according to ICH guidelines. The linear 
regression analysis indicated a good linearity 
over a wide concentration range (10 – 60 ng/ml) 
with regard to peak area. The mobile phase 
compositions were prepared with appropriate 
ratios of acetonitrile, water and buffer (70 Mm). 
The adjustment of pH 4.5 was made using ortho-
phosphoric acid. It was detected that the best 
determination of amitriptyline was attained with a 
mobile phase composed of acetonitrile and buffer 
(pH 4.5) at (60:40 % v/v) ratio and a flow rate of 
1 ml/min. 
 
Calibration curve and linearity 
 
The test was test on ten concentrations (10, 15, 
20, 25, 30, 35, 40, 45, 50, 60 ng/ml) and was 
repeated three times for each concentration. No 
significant difference was observed in the slopes 
of standard curves. The observed straight line 
equation was, y = 0.033x + 0.0056 with r2 value 
of > 0.9996.  
 
Precision, accuracy and recovery 
 
The precision of the developed analytical method 
was done by measuring the standard 
amitriptyline concentration (30 ng/ml). 
Measurement was done repeatedly six times for 
each injection. The relative standard deviation 
(RSD of the results was found to be 0.51, while 
the percentage recovery was found to be 
100.056  ±  0.51 %, as shown in (Table 1). 
 
Table 1: Concentration of amitriptyline (30 ng/ml) 







1 30.07 100.23 
2 30.12 100.40 
3 29.87 99.57 
4 30.23 100.80 
5 29.98 99.93 
6 29.83 99.43 
Mean 30.017 100.05 
% RSD 0.153 0.51 
 
The accuracy of the assay method was 
evaluated at two concentration levels of 
amitriptyline, i.e., higher concentration (60 ng/ml) 
and lower concentration (10 ng/ml) and repeated 
six times for each injection. The percentage of 
recoveries and % RSD were calculated from the 
slope and y-intercept of the calibration curve. 
The recovery values obtained were in the range 
of 98.3 to 100.85 % confirming accuracy of the 
developed method (Table 2). The percentage 
recovery of the lowest concentration was 99.71 ± 
0.99 % and that of the highest concentration was 
100.001 ± 0.185 %. 
 
Limits of detection (LOD) and of 
quantification (LOQ) 
 
The signal-to-noise ratio of 3.3:1 and 10:1 were 
considered as LOD and LOQ and were found to 
be 0.40 and 1.0 ng/ml, respectively. 
 
Selectivity and specificity  
 
The results indicated that there was no overlap 
between the analyte and the rest materials, and 
the retention time of amitriptyline was found to be 
6.15 min. The specificity of the method was 
shown by the lack of interfering endogenous 
 











1. 10.33 99.15 60.1 99.7 
2. 10.31 98.3 60.32 99.87 
3. 10.37 100.85 60.6 100.07 
4. 10.33 99.15 60.76 100.19 
5. 10.36 100.43 60.72 100.16 
6. 10.36 100.43 60.51 100.01 
Mean 10.34 99.71 60.5 100.00 
% RSD 0.02 0.99 0.25 0.185 
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plasma components in the chromatograms of 




Stability (short-term) was validated for 6 and 48 
h, both at room temperature. Long-term stability 
was evaluated after storage of the test samples 
at - 80 ºC for 30 days. All stability experiments 
were carried out against freshly spiked 
calibration standards.  
 
Analysis of amitriptyline in plasma by the 
developed method 
 
The developed HPLC method was successfully 
used to quantify amitriptyline in plasma samples, 
following oral administration of drug and 
activated charcoal. The resulting drug 
concentrations measured in plasma collected 
after 2 h of dosing. The concentrations of drug 
obtained in plasma in all four animal groups are 
presented in (Table 3). One way analysis of 
variance (ANOVA) was used to interpret the 
results obtained after plasma analysis in all 
groups and the results were presented well in 
(Table 3). 
 
The statistical results are also displayed in Table 
4 in terms of degree of freedom, p-value, etc. 
The statistical size of the effect was also be 
calculated as in Eq 1. 
 
r2 = ŋ2 = SSamonggroup/SStotal = 3949.375/6485.220 
= 0.609………..(1) 
 
This value (r2 = 0.609) can also be explained on 
the basis of the guidelines by Cohen, which 
stipulates that 0.1, 0.25 and 0.4 represents small, 
medium and large effect sizes, respectively. 
Therefore, it is evident from the r2 value that it is 
a size of a large impact. Student-Newman-Keuls 
method was used to identify the sources of these 
differences for multiple comparison tests, and the 
results are shown in Table 5. 
 
The results of statistics indicated that there were 
significant differences between the average 
concentration of amitriptyline without the use of 
activated charcoal, and the average 
concentration of amitriptyline when the activated 
charcoal concentrations i.e. 200 mg/ml, 100 
mg/ml respectively, were used. Fig. 2 illustrates 
the differences between the arithmetic mean 
concentrations of the drug. 
Table 3: Drug concentrations in blood sample following administration of 2.5 mg mitriptyline to rats 
 
Blood drug concentration (ng/ml, n = 8) Amitriptyline (2.5 
mg) Group-IV Group-III Group-II Group-I 
19.6 35.5 36.5 41.2  
13.8 20.4 44.3 42.9  
13.0 14.4 39.4 23.0  
13.1 16.8 39.8 24.9  
9.3 15.3 22.0 23.5  
13.6 19.9 51.2 52.9  
2.5 9.0 30.8 25.7  
10.8 18.9 36.1 58.8  
11.96 ± 4.85 18.81 ± 7.64 37.51 ± 8.71 36.61 ± 14.30 Mean ± SD 
 
 
Table 4: Results of statistical analysis 
 
Source of variation DF Sum of squares Mean square F-value P-value 
Between Groups 3 3949.375 1316.458 14.536 < 0.001 
Residual 28 2535.845 90.566   
Total 31 6485.220    
 
 
Table 5: Student-Newman-Keuls Method for all pair-wise multiple comparison procedures 
 
Comparison Differences of means P q p P < 0.050 
Row 2 vs. Row 4 25.550 4 7.594 < 0.001 Yes 
Row 2 vs. Row 3 18.700 3 5.558 < 0.002 Yes 
Row 2 vs. Row 1 0.900 2 0.267 < 0.851 No 
Row 1 vs. Row 4 24.650 3 7.326 < 0.001 Yes 
Row 1 vs. Row 3 17.800 2 5.290 < 0.001 Yes 
Row 3 vs. Row 4 6.850 2 2.036 < 0.161 No 
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Figure 2:  Statistical graph explains the differences between the arithmetic mean concentrations; *p <0.05, **p 
<0.01, ***p < 0.001 
 
It is clear from the above plot that there is no 
statistical difference between the mean 
concentration of amitriptyline when 100 and 200 




In the present study, LOD and LOQ were 0.40 
and 1.0 ng/ml, respectively, which indicate an 
adequate sensitivity of the developed method. 
Selectivity was performed to differentiate 
amitriptyline from rest of the material present in 
the sample and to determine the retention time of 
amitriptyline. The retention time of the 
amitriptyline was 6.15 min in all samples, which 
means that there was no overlap between the 
analyte and the rest materials. The stability 
experiments results were always well within ± 15 
% of deviation, and thus indicates that no 
degradation of amitriptyline occurred under the 
defined conditions. 
 
The results of the analysis indicated that, using 
the half of the standard dose (100 mg/ml) of the 
activated charcoal gave comparable effect to that 
of the standard dose (200 mg/ml) in reducing the 
concentration of amitriptyline in the blood as 
evidenced by the plasma concentration of drug 
as indicated in (Table 3). On the other hand, 
using quarter of the standard dose (50 mg/ml) of 
activated charcoal did not produce a significant 
effect in reducing the drug concentration in blood 
after 2 h of dosing.  
 
The differences in the mean values among the 
treatment groups are greater than would be 
expected by chance; there is a statistically 
significant difference (p < 0.001). Since the level 
of significance calculated (p < 0.001) is smaller 
than the significance level of statistical study 
(0.05), there was no significant differences for 
the average concentrations of amitriptyline 
between the control group and the other two 
groups of focus those were given 200 mg/ml and 
100 mg/ml of activated charcoal (Table 4). 
 
There was statistically significant difference 
between the mean concentration of amitriptyline 
when 50 and 200 mg/ml activated charcoal 
concentration was used; same was observed 
when 50 and 100 mg/ml activated charcoal 
concentration was used. However, no statistically 
significant difference was found when 100 and 
200 mg/ml activated charcoal concentrations 
were used. No statistically significant differences 
between the average concentration of 
Amitriptyline without the use of activated 
charcoal, and the average concentration of 
Amitriptyline when 50 mg/ml of activated 
charcoal concentration was used. 
 
It was also observed that a small dose of 
activated charcoal (100 mg/ml) produced an 
effect that was comparable to that of the highest 
standard dose of the activated charcoal (200 
mg/ml) in terms of reducing the toxic 
concentration of amitriptyline in the blood of rats. 
We also note that the use of half of the minimum 
dose of the standard dose of the activated 
charcoal, 50 mg/ml had a very limited effect in 
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The developed RP-HPLC method enables 
determination of amitriptyline with good 
separation and resolution of the chromatographic 
peaks. Furthermore, using half of the standard 
dose of activated charcoal produced a 
comparable effect to the standard dose in 
reducing blood drug concentration. The method 
is simple and accurate, and may be considered 
for routine analysis of amitriptyline in biological 
samples, raw materials and pharmaceutical 
formulations, as well as for therapeutic drug 
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